cmvcrv.wiki • Professional Insights • Expert Commentary • Resource Center
cmvcrv.wiki

New Details,associated peptide

Unveiling the Latency Associated Peptide (LAP): A Crucial Component in TGF-β Signaling oleh WJ Burlingham·2023·Dirujuk 4 kali—Nakamura et al found that TGFβ1 was present in a latent (latency-associated peptide[LAP]–associated) form on the surface of CD4+CD25+Tregs but 

:ペプチドlatency associated

A
Howard Clark

studies '' data patterns and performance metrics with user-focused content delivery across YouTube and TikTok

Published on

Executive Summary

latency associated peptide oleh WJ Burlingham·2023·Dirujuk 4 kali—Nakamura et al found that TGFβ1 was present in a latent (latency-associated peptide[LAP]–associated) form on the surface of CD4+CD25+Tregs but 

The term "latency associated peptide とは" (latency associated peptide to wa), which translates to "what is latency associated peptide," points to a fundamental element within the intricate biological pathways governing cell growth, differentiation, and immune responses. At its core, the Latency Associated Peptide (LAP) is an integral part of the transforming growth factor beta (TGF-β) superfamily. It plays a critical role in regulating the activity of TGF-β, a potent cytokine with diverse physiological functions. Understanding LAP is key to comprehending how TGF-β's potent signaling is controlled and modulated within the body.

The Molecular Structure and Formation of LAP

The Latency Associated Peptide (LAP) is essentially the propeptide portion of the TGF-β molecule. During the biosynthesis of TGF-β, the protein is synthesized as a precursor that includes the LAP segment. This LAP region is covalently bound to the mature TGF-β cytokine through disulfide bonds within the endoplasmic reticulum. This intricate covalent binding is foundational to the formation of the latent TGF-β complex.

Specifically, the N-terminal portion of TGF-β is referred to as LAP. When TGF-β is cleaved by a protease, the LAP is released. However, in its native state, LAP remains associated with the TGF-β dimer, forming a latent complex. This association is often described as a noncovalent association between the TGF-β propeptide dimer (also known as LAP) and the active cytokine. This intricate structural arrangement is pivotal for maintaining TGF-β in an inactive, or "latent," state. The endoplasmic reticulum and post-Golgi compartments are key cellular locations where these crucial processing steps occur, leading to the formation of the latent TGF-β complex.

The Role of LAP in Latency and Activation

The primary function of LAP is to confer latency upon TGF-β. By binding to the active cytokine, LAP effectively sequesters it, preventing it from interacting with its cellular receptors and initiating downstream signaling pathways. This sequestering agent role is crucial for maintaining cellular homeostasis and preventing uncontrolled TGF-β activity, which can lead to various pathological conditions.

The activation of TGF-β from its latent complex involves the release of LAP. This release can be triggered by a variety of stimuli and cellular mechanisms. For instance, the cleavage of LAP by specific proteases is a critical step in liberating the active TGF-β. Research has identified specific regions within LAP that govern the cooperative assembly and stability of the latent TGF-β complex, highlighting the intricate molecular details that control its activation. The conformational changes within LAP are also under investigation, with studies exploring the switching between transforming growth factor beta-1 bound and unbound states.

LAP's Broader Biological Significance

Beyond its direct role in TGF-β latency, LAP has been implicated in various immune and cellular processes. Studies have shown that LAP can bind to TGF-β1, forming a latent complex. While initially presumed to solely function as a sequestering agent, emerging research suggests LAP might have more active roles. For example, a subset of regulatory γδ T cells have been found to express LAP, which is a membrane-bound TGF-β1. This indicates a potential role for LAP in cell-cell interactions and immune modulation.

Furthermore, LAP has been shown to interact with other molecules. It can be disulfide-linked to LTBP (Latent Transforming Growth Factor Beta-Binding Protein), another component of the latent TGF-β complex, contributing to its overall stability and presentation. Research has also explored the binding of LAP to specific integrins, such as αvβ6, on the surface of oral squamous carcinoma cells, suggesting potential roles in cancer progression and cell adhesion.

The study of LAP is an active area of scientific inquiry. Techniques such as ELISA (Enzyme-Linked Immunosorbent Assay) are employed to detect and quantify LAP and its associated complexes, aiding in the understanding of its role in various biological and disease contexts. The crystal structure of Latency Associated Peptide has also been determined, providing valuable insights into its molecular architecture and interactions.

In summary, the latency associated peptide (LAP) is a fundamental protein that plays a crucial role in regulating the activity of TGF-β. Its function as a component of the latent TGF-β complex is vital for maintaining cellular balance and preventing uncontrolled signaling. As research progresses, a deeper understanding of LAP's multifaceted roles in immunity, cell signaling, and disease is continually emerging.

Related Articles

Frequently Asked Questions

Here are the most common questions about .

このため、TGF-βのN末端側の部分はLAP (latency-associated peptide)と呼ばれるようになります。TGF-βが刀にあたるとすると、LAPは刀の鞘(さや)にあたります。当時私 
Latency Associated Peptide (TGF-β1) (LAP)
Binding of TGF-β1 latency-associated peptide (LAP) to
11 Mar 2020—Structural insights into conformational switching inlatency-associated peptidebetween transforming growth factor beta-1 bound and unbound states.

Leave a Comment

Share your thoughts, feedback, or additional insights on this topic.

Explore More